ImmunityBio’s ANKTIVA shows promise, but modest growth, high cash burn, and rising competition raise red flags. Read why IBRX stock is a sell.

Investing at least part of the initial $1,000 in an artificial intelligence (AI) stock is a smart move. Despite impressive ...

Child mortality has been halved in the last 25 years. Building on this progress, new innovations in immunization are working ...

This study presents a comprehensive survey on Quantum Machine Learning (QML) along with its current status, challenges, and perspectives. QML combines quantum computing and machine learning to solve ...

Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is a progressive neurological disease with an ...

PROTEUS, a system designed to harness “directed evolution,” can speed the process up by years, or even decades.

With the singing of the Sunshine Genetics Act, Florida has positioned itself as a national leader in pediatric genetic ...

In industry parlance, Cargo had become a “zombie,” an unprofitable company with little hope for growth, but enough money to ...

An international research team led by Justus Liebig University Giessen (JLU) and the Joint FAO/IAEA Center of Nuclear ...

In recent years Philadelphia has become a hub of scientific innovations, fueled largely by the life sciences sector and an ...

The funding will support Gallant’s treatment for refractory feline chronic gingivostomatitis, which is in development.